These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17665182)

  • 1. Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia.
    Doki K; Homma M; Kuga K; Aonuma K; Sakai S; Yamaguchi I; Kohda Y
    Eur J Clin Pharmacol; 2007 Oct; 63(10):951-7. PubMed ID: 17665182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia.
    Doki K; Homma M; Kuga K; Kusano K; Watanabe S; Yamaguchi I; Kohda Y
    Eur J Clin Pharmacol; 2006 Nov; 62(11):919-26. PubMed ID: 16944116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCN5A promoter haplotype affects the therapeutic range for serum flecainide concentration in Asian patients.
    Doki K; Homma M; Kuga K; Aonuma K; Kohda Y
    Pharmacogenet Genomics; 2013 Jul; 23(7):349-54. PubMed ID: 23635804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of CYP2D6 genotypes on age-related change of flecainide metabolism: involvement of CYP1A2-mediated metabolism.
    Doki K; Homma M; Kuga K; Aonuma K; Kohda Y
    Br J Clin Pharmacol; 2009 Jul; 68(1):89-96. PubMed ID: 19660006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of Pharmacogenetic Information for Therapeutic Drug Monitoring of an Antiarrhythmic Drug].
    Doki K
    Yakugaku Zasshi; 2018; 138(9):1145-1150. PubMed ID: 30175758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2D6 genotype affects age-related decline in flecainide clearance: a population pharmacokinetic analysis.
    Doki K; Homma M; Kuga K; Aonuma K; Kohda Y
    Pharmacogenet Genomics; 2012 Nov; 22(11):777-83. PubMed ID: 22941032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity.
    Doki K; Sekiguchi Y; Kuga K; Aonuma K; Homma M
    Drug Metab Pharmacokinet; 2015 Aug; 30(4):257-62. PubMed ID: 26195225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemolysis alters plasma flecainide levels in newborn infants.
    Vento M; Tudela BF; Escrig R; Sáenz P; Sánchez A; Cano A
    Acta Paediatr; 2007 Mar; 96(3):466-8. PubMed ID: 17407483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete Heart Block Secondary to Flecainide Toxicity: Is It Time for CYP2D6 Genotype Testing?
    Poh BH; Lee JH; Abdul Haium AA; Choo TLJ
    Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32561613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of serum flecainide trough levels in patients with tachyarrhythmia.
    Homma M; Kuga K; Doki K; Katori K; Yamaguchi I; Sugibayashi K; Kohda Y
    J Pharm Pharmacol; 2005 Jan; 57(1):47-51. PubMed ID: 15638992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects.
    Lim KS; Jang IJ; Kim BH; Kim J; Jeon JY; Tae YM; Yi S; Eum S; Cho JY; Shin SG; Yu KS
    Clin Ther; 2010 Apr; 32(4):659-66. PubMed ID: 20435235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and electrocardiographic effects of a new controlled-release form of flecainide acetate: comparison with the standard form and influence of the CYP2D6 polymorphism.
    Tennezé L; Tarral E; Ducloux N; Funck-Brentano C
    Clin Pharmacol Ther; 2002 Aug; 72(2):112-22. PubMed ID: 12189358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term evaluation of flecainide acetate in supraventricular tachyarrhythmias.
    Mary-Rabine L; Telerman M
    Acta Cardiol; 1988; 43(1):37-48. PubMed ID: 3132008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of maternal flecainide concentrations and therapeutic effect in fetal supraventricular tachycardia.
    Vigneswaran TV; Callaghan N; Andrews RE; Miller O; Rosenthal E; Sharland GK; Simpson JM
    Heart Rhythm; 2014 Nov; 11(11):2047-53. PubMed ID: 25068572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects.
    Lim KS; Cho JY; Jang IJ; Kim BH; Kim J; Jeon JY; Tae YM; Yi S; Eum S; Shin SG; Yu KS
    Br J Clin Pharmacol; 2008 Nov; 66(5):660-6. PubMed ID: 18754843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory Fetal Supraventricular Tachycardia with Hydrops Successfully Converted by Intraperitoneal Flecainide in the Fetus: A Case Report.
    Vedel C; Vejlstrup N; Jensen LN; Ekelund CK; Nørgaard LN; Harmsen L; Petersen OB; Jaeggi E; Gembruch U; Sundberg K
    Fetal Diagn Ther; 2020; 47(9):717-720. PubMed ID: 32570238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of supraventricular tachycardia with flecainide acetate: a case report.
    Amano K; Harada Y; Shoda T; Nishijima M; Hiraishi S
    Fetal Diagn Ther; 1997; 12(6):328-31. PubMed ID: 9475360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.